3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Thoracic
1
Conditions
Stomach Neoplasms
1
Hyperphagia
1
Colorectal Neoplasms
1
Interventions
Fluorouracil
56
Specimen Handling
51
Oxaliplatin
49
Leucovorin
46
Magnetic Resonance Spectroscopy
45
Bevacizumab
43
Gemcitabine
39
Irinotecan
30
Cetuximab
27
Nivolumab
25
130-nm albumin-bound paclitaxel
25
Cisplatin
24
Biopsy
24
pembrolizumab
22
Paclitaxel
22
Capecitabine
19
atezolizumab
18
durvalumab
14
Taxes
14
Folfox protocol
14
Carboplatin
13
X-Rays
12
Radiotherapy
12
Cyclophosphamide
12
fludarabine
11
dehydroftorafur
10
Radiation
10
Albumin-Bound Paclitaxel
10
Surgical Procedures, Operative
9
Immunoglobulin G
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Dietary Supplements
×
Gastrointestinal
×
30 days
×
Clear all
NCT07604857
2026-05-22
BRIDGE-GC
The Catholic University of Korea
Phase NA
Completed
55 enrolled
NCT07599501
2026-05-20
NUTRICOLOR
Istituto Clinico Humanitas
Phase NA
Not yet recruiting
190 enrolled